+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Trial Imaging - Global Market Trajectory & Analytics

  • ID: 5303292
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Bioclinica, Inc.
  • ERT Clinical
  • Image Core Lab
  • Ixico PLC
  • Navitas Life Sciences
  • Prism Clinical Imaging
Global Clinical Trial Imaging Market to Reach $1.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Clinical Trial Imaging estimated at US$899.7 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027. Operational Imaging Services, one of the segments analyzed in the report, is projected to record a 5% CAGR and reach US$409.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Project & Data Management segment is readjusted to a revised 6% CAGR for the next 7-year period.



The U.S. Market is Estimated at $242.6 Million, While China is Forecast to Grow at 8.8% CAGR

The Clinical Trial Imaging market in the U.S. is estimated at US$242.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$281.4 Million by the year 2027 trailing a CAGR of 8.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Reading & Analytical Services Segment to Record 5.6% CAGR

In the global Reading & Analytical Services segment, USA, Canada, Japan, China and Europe will drive the 5.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$128.2 Million in the year 2020 will reach a projected size of US$183.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$179.8 Million by the year 2027, while Latin America will expand at a 6% CAGR through the analysis period.

Select Competitors (Total 42 Featured):
  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biotelemetry, Inc.
  • Cardiovascular Imaging Technologies, LLC
  • ERT Clinical
  • Icon PLC
  • Image Core Lab
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Lyscaut Medical Imaging Company
  • Medical Metrics
  • Navitas Life Sciences
  • Parexel International Corporation
  • Perspectum Diagnostics
  • Prism Clinical Imaging
  • Quotient Sciences
  • Radiant Sage LLC
  • Resonance Health
  • Worldcare Clinical, LLC
Frequently Asked Questions about the Global Market for Clinical Trial Imaging

What is the estimated value of the Global Market for Clinical Trial Imaging?

The Global Market for Clinical Trial Imaging was estimated to be valued at $899.7 Million in 2020.

What is the growth rate of the Global Market for Clinical Trial Imaging?

The growth rate of the Global Market for Clinical Trial Imaging is 5.4%, with an estimated value of $1300.0 Million by 2027.

What is the forecasted size of the Global Market for Clinical Trial Imaging?

The Global Market for Clinical Trial Imaging is estimated to be worth $1300.0 Million by 2027.

Who are the key companies in the Global Market for Clinical Trial Imaging?

Key companies in the Global Market for Clinical Trial Imaging include Bioclinica, Inc., Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies, LLC, ERT Clinical, Icon PLC, Image Core Lab, Intrinsic Imaging LLC and Lyscaut Medical Imaging Company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bioclinica, Inc.
  • ERT Clinical
  • Image Core Lab
  • Ixico PLC
  • Navitas Life Sciences
  • Prism Clinical Imaging

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biotelemetry, Inc.
  • Cardiovascular Imaging Technologies, LLC
  • ERT Clinical
  • Icon PLC
  • Image Core Lab
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Lyscaut Medical Imaging Company
  • Medical Metrics
  • Navitas Life Sciences
  • Parexel International Corporation
  • Perspectum Diagnostics
  • Prism Clinical Imaging
  • Quotient Sciences
  • Radiant Sage LLC
  • Resonance Health
  • Worldcare Clinical, LLC
Note: Product cover images may vary from those shown